Dermatomyositis
Polymyositis Inclusion
Body Myositis
Systemic Lupus Erythematosus
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Assistant Attending Physician, Hospital for Special Surgery
American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Rheumatology
Lupus and Antiphospholipid Syndrome Center of Excellence Research Fund Award, 2016
F31 Predoctoral Fellowship, NIAMS, 2008-201
SUNY Upstate Medical University, Syracuse
NewYork-Presbyterian - Weill Cornell Medical Center, New York
NewYork-Presbyterian - Weill Cornell Medical Center, New York
Hospital for Special Surgery, New York
English, Spanish
For all publications, please see the PubMed listing.
Currently studying the role of cell-free mitochondrial DNA in triggering interferon production and disease flares in patients with systemic lupus erythematosus, as well as the effect of medications used to treat lupus patients on mitochondrial DNA release.
Additionally, working to identify clinical features in a large cohort of lupus patients that may allow us to better define subgroups of patients.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Fernandez as of December 05, 2019.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.